Premium
CLINICAL OUTCOMES AND DIAGNOSIS‐TO‐TREATMENT INTERVAL IN PATIENTS WITH NK/T‐CELL LYMPHOMA: 7‐YEAR FOLLOW‐UP OF THE NKEA STUDY
Author(s) -
Yamaguchi M.,
Suzuki R.,
Oguchi M.,
Miyazaki K.,
Taguchi S.,
Amaki J.,
Maeda T.,
Kubota N.,
Maruyama D.,
Terui Y.,
Sekiguchi N.,
Takizawa J.,
Tsukamoto H.,
Murayama T.,
Ando T.,
Matsuoka H.,
Hasegawa M.,
Wada H.,
Sakai R.,
Kameoka Y.,
Tsukamoto N.,
Choi I.,
Masaki Y.,
Shimada K.,
Fukuhara N.,
Utsumi T.,
Uoshima N.,
Kagami Y.,
Asano N.,
Katayama N.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.86_2630
Subject(s) - medicine , lymphoma , clinical trial , incidence (geometry) , biopsy , t cell lymphoma , surgery , gastroenterology , physics , optics